Managing Metabolic Side Effects in Schizophrenia

December 8, 2021 | Podcasts

Individuals with schizophrenia are at high risk of obesity, elevated lipids, increased insulin resistance, diabetes, and cardiovascular disease. On average, people with schizophrenia die 20–25 years sooner than those without schizophrenia. How can we spot metabolic side effects early in...

Read More

A Child Psychiatry Research Update Extravaganza - Part 1

December 6, 2021 | Podcasts

From melatonin for sleep-onset insomnia to electroconvulsive therapy for severe adolescent mood disorder to steroid-induced psychosis to the risk of stimulant-induced psychosis in youth with ADHD, and MORE! In this two-part episode series, Mara and Dr. Feder will tackle various...

Read More

An Antidepressant Diet

November 29, 2021 | Podcasts

An interview with Drew Ramsey on nutritional psychiatry. Chris Aiken, MD, Kellie Newsome, PMHNP, and Drew Ramsey, MD, have disclosed no relevant financial or other interests in any commercial companies pertaining to this educational activity. [wcm_nonmember]CME: Podcast CME Post-Tests are...

Read More

Gender-Based Differences in the Treatment of Schizophrenia

November 22, 2021 | Podcasts

How does schizophrenia differ between men and women? And are there adjunctive treatments that can improve outcomes for female patients with schizophrenia? In this podcast, Dr. Kulkarni and I will tackle these questions.  [wcm_nonmember]CME: Podcast CME Post-Tests are available using...

Read More

What You Need to Know About Kloxxado

October 28, 2021 | Podcasts

  On April 30th of this year, the FDA approved Kloxxado, a naloxone nasal spray that contains 8mg of naloxone per dose, which is twice as much as the most common formulation: Narcan. But what distinguishes Kloxxado distinguishes from the many other ways...

Read More